Evaluating the Prognostic Role of Glucose-to-lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors in First Line: a Study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
Clinical and Translational Oncology(2025)
关键词
Renal cell carcinoma,Glucose-to-lymphocyte ratio,GLR,Tyrosine kinase inhibitor
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要